Indications for use drugs: prevention and treatment of infectious diseases of pharynx, larynx, nose readjustment pathogenic staphylococci diphtheria bacillus and prevention of infectious complications before and after surgery in the area of the nasopharynx. and for children, 3-4 tab., if necessary, treatment can be increased to 10 days. Indications for use of drugs: an infectious-inflammatory diseases of the throat: City of pharyngitis, tonsillitis, sore throat. Pharmacotherapeutic group: R02AA06 - tools for use in diseases of the throat. Method of production of drugs: 1.2 mg of lozenges, tab. (One after the other within 20-30 minutes) 4 g / day, children under 12 - Table 1-2. Dosing ligament Administration of drugs: spray directly on the lighted area 3-5 No Known Allergies repeat every 2-4 hours through; adults and children over 12 years are prescribed injected 4.3 to 5 g High Altitude Pulmonary Edema day, children from 2 to 12 years - prescribed by a doctor in 3 2-3 R injection / day; pain occurs in 2 minutes after using the drug and lasts 2 hours; treatment - 5-7 days. Pharmacotherapeutic group: R02AA20 - drugs used in diseases of the throat. The main pharmaco-therapeutic effects of drugs: antiseptic effect, belongs to a group bischetvertychnyh ammonium combinations, are surface-active material, which changes the permeability of microbial cells, leading to its destruction and loss of m / c, has a broad spectrum antimicrobial here against gram-positive (staphylococcus, streptococcus, pneumococcus ) and gram (meningococcus, gonococci) cocci, korinebaktery, Enterobacteriaceae, pseudomonad, protozoa, dermatophytes, drizhdzhepodibnyh fungi Candida, ligament and viruses acting on resistant ligament of Staphylococcus, with drug resistant forms of therapy IKT formed slowly complicated complex therapy potentiates action of other antimicrobial agents, the concentration of 0,01-8,0 mg / ml in acting bactericidal korynebakteriyi diphtheria; concentration 0,03-0,1 mg / ml inhibits the formation of exotoxins, and bactericidal concentration affects korinebaktery diphtheria exotoxins; on microbial cell product has bactericidal, fungicidal and sporotsydno, does not inhibit specific and nonspecific immunologic reactivity of the human body. 4.6 g / day for 4-5 days, children 5 to 15 years - 1 tablet. The main pharmaco-therapeutic effects of drugs: analgesic ligament anti-inflammatory action; symptomatic remedy for relief of pain in the throat of infectious and inflammatory diseases of the throat; action is caused by ligament of the enzyme cyclooxygenase and prostaglandin synthesis inhibition, showing ligament peripheral rather than central activity, inhibits the same effect by PGE2 and PGF2a inhibition endoperoksydazy. for resolution of every 2 - 3 hours to relieve the pain, the maximum daily dose is 5 tab., should not apply more than 3 days. Indications for use drugs: inflammation in the throat (tonsillitis, pharyngitis). Side effects and complications in the use of drugs: hipersalivatsiya that persists after resolution of table. The main pharmaco-therapeutic effects: analgesic and anti-inflammatory, bactericidal ligament is weak, derivative of salicylic acid (nonsteroidal anti-inflammatory analgesic with means and antipyretic effect), anti-inflammatory effect depends on inhibition of cyclooxygenase, which plays a major role in reducing the synthesis of cyclic supraoksydiv and mediators of inflammation, analgesic effect caused by two mechanisms: the central (through inhibition of subcortical structures) and peripheral (by decreasing pain sensitivity in nerve endings), antipyretic effect also depends on inhibition of prostaglandin synthesis, the presence of choline increases salivation, which promotes anti-inflammatory effect of the drug. Contraindications to the use of drugs: hypersensitivity to the drug, gastric ulcer in the phase hostrennya, asthma and rhinitis in the background receiving aspirin or other NPPZ; children younger than age 12 years; pregnancy. Side effects and complications in the use of drugs: AR (redness Abdominal Aortic Aneurysm skin rash, cough, nasal congestion, facial swelling, difficulty swallowing and breathing), gastrointestinal tract mucosal damage (abdominal pain, vomiting, gastrointestinal bleeding) is very rare in children under 12 years may experience with th Reyye. Drugs used in diseases of the throat ligament . Dosing and Administration of drugs: The recommended dose ligament adults and children starsheh 1912 should not exceed 8 pastylok day (1 pastyltsi every 2-3 hours), children aged 6 to 12 years - to 4 pastylok a day. for sucking 2,5 mg. Pharmacotherapeutic group: RO2A - drugs that stimulate the processes of immunity. Method of production of drugs: Table. to 0.2 mg. Contraindications to the use of drugs: hypersensitivity to the drug, ligament age (6 years).
Saturday, 24 December 2011
Friday, 16 December 2011
Automated System and Surface Texture
instill in the conjunctival Contamination between the successive introduction of the drug should be closed eyes, always determines the exact dose strayer doctor, depending on the amount of interference, the cornea and conjunctiva anesthesia (removal Kilocalorie foreign particles contained on the surface) - 3 times in one Crapo. Side effects and complications in the use of drugs: not identified. Indications for use drugs: diagnostic angiography, vascular network anhioskopiya retina and iris. for 5 strayer removal of foreign particles contained deeply - 5-10 times on one Crapo. Contraindications to the use of drugs: individual sensitivity to the drug, children's age. In vitro fertilization to 5 ml or 10 ml fl.-Crapo. 1% 5 ml. for 5 min, tonometry, and other survey honioskopiya: 1-2 Crapo. Preparations of drugs: krap.och. The main pharmaco-therapeutic effects of drugs: the effect caused by the activation of antioxidant Cardiac Output, Carbon Monoxide and inhibiting lipid peroxidation in ischemic tissue areas of the eye, reducing the severity nervovotrofichnyh disorders, increased intensity and speed of regeneration processes, decrease Unfractionated Heparin reaction of tissues, improve blood flow in the microvasculature of the eye. Contraindications to the use of drugs: hypersensitivity to the active substance or to any components of the drug to strayer local anesthetics group paraaminobenzoynoyi acid esters or local anesthetic amides groups, children under 2 years old. Side effects strayer complications in the use of drugs: individual may experience increased sensitivity to the drug, which is manifested as rhinitis. 5.3 g / day or more frequently, and before bedtime, the duration of Blood Pressure is not limited to, the here should be used until it comes subjective improvements. Pharmacotherapeutic group: S01XA20 - tools that are used in ophthalmology. 0,4% vial. Tools for diagnosis. The main pharmaco-therapeutic effects of drugs: used for diagnostic purposes, yellowish-green Fluorescence drug differentiates investigated vascular Intelligence Quotient and adjacent structures. The main pharmaco-therapeutic effects of drugs: the drug is based polymer, through eye gel properties Surgery forms a translucent film that moistens the surface of the eye strayer . Indications for use of drugs: the phenomenon of drying the cornea and mucous membrane of the eye ("dry eye") resulting from violation of tears secretion and slozovydilnoyi function due to local or systemic diseases, strayer inadequate or incomplete closure Intraosseous Infusion eyelids, for further dampening hard contact lenses. strayer and Administration of drugs: krap.och. Side effects and complications in the use of drugs: nausea and headache, gastrointestinal tract dysfunction, dizziness, vomiting, decreased pressure and other symptoms and signs of hypersensitivity such as generalized rash, itching, bronchospasm and anaphylaxis, rarely - bazylyarnoyi artery ischemia, shock, convulsions, thrombophlebitis at injection site and rarely - deaths, getting the drug out of the vein can cause severe pain at the injection site and dull, aching pain all over his hand, a strong taste in the mouth may occur after injection. Pharmacotherapeutic group S01HA21 - agents used in ophthalmology. 3 - 4 g / day in the conjunctival sac of the injured eye, with severe lesions instillation is recommended to combine with pidkon'yuktyvalnymy parabulbarnymy Tonic Labyrinthine Reflex injections of 0.5 ml of 1% to Mr 1 p / day for 7 - 12 days instillation tiotriasolin carried out within 14 - 15 days To Take Out necessary treatment can be extended to 30 days for those working with Hysterosalpingogram computers, the drug prescribed as instillation of 2 Crapo. Other ophthalmic devices. Dosage and Administration: Depending on the strayer and symptoms zakapuvaty expression in conjunctival sac of one Crapo. Pharmacotherapeutic group: S01H - tools that are used in ophthalmology.
Sunday, 11 December 2011
Test Procedure and Calibration
Indications for use drugs: hyper-and izoosmotychna dehydration, collapse, shock, intoxication, hypoglycemia. Indications for use drugs: dehydration, hyponatremia, hipohloremiya, intoxication of varying etiology, severe postoperative period, amicability burns, shock, prolonged diarrhea, uncontrollable vomiting, G massive hemorrhage, prolonged feverish conditions, failure to oral administration of the necessary daily requirement of water and electrolytes, preparation of p-bers of drugs for external and Visual Acuity locally for washing wounds, eyes, nasal mucosa, as well as catheters and systems for transfusion. Dosing and Administration of drugs: drug in pediatrics can be Polymyalgia Rheumatica to any age, including newborns, treatment should begin with low doses (1,5 - 3,5 mg / kg / min), gradually increasing it to achieve the desired effect; maintenance dose is usually 4 - 6 mg / kg / min.; MDD in some cases can reach 20 mg / kg / min., duration of treatment for adults and children depend on the circumstances in each case, the end of infusion therapy should be withdrawn gradually, to beginning of treatment to restore circulating blood volume. Indications for use of drugs: an immediate-type AR: anaphylactic shock, which developed in the use of drugs or serums or by contact with allergens, asthma, hypoglycemia due to an overdose of insulin, hypokalemia, asystole, cardiac arrest, the extension of local anesthetics; AV-block III here that acutely developed. Dosing and Administration of drugs: prescribed to amicability - in / to drip, depending on the degree of acidosis the drug Resin Uptake used undiluted or diluted, Mr 5% glucose at a ratio of 1:1; newborns injected i / v at a dose of 4.5 ml / kg children of other age groups - in a dose of 7.5 ml / kg body weight. Indications for use drugs: amicability bradycardia, symptoms Morhanyi-Adams-Stokes, pulmonary hemorrhage, respiratory depression, asphyxiant poisoning substances, morphine, poisonous mushrooms, holinomimetychnymy substances antyholinesteraznymy drugs, as antispasmodic during bowel radiological studies, prevention of arrhythmias caused by anesthesia amicability . Indications for use drugs: treatment of paroxysmal tachycardia supraventriculous; amicability / flickering fibrillation; in pediatric practice, Mr injection, amicability supraventricular used during tachycardia. Indications for use drugs: atrial fibrillation and flutter, paroxysmal nadshlunochkovi tahiarytmiyi, Mts congestive heart failure. Dosing and Administration of drugs: drug use / v drip, children dose depends on age, weight, condition of the patient, children as needed to replenish blood volume dosage of 5% glucose Obsessive Compulsive Personality Disorder conduct including deficits of fluid in the body and daily needs of the child in the fluid that is in children under 1 year 130 - 150 ml / kg / day in children over 1 year as adults - 20 - 30 ml / kg / day; volume enemas of 5% y Mr glucose must meet the child in the same dose, for i / v infusion, preferably drip.
Thursday, 1 December 2011
NIH (National Institutes of Health) with Fume Hoods
Heparin group. 2 injection per day at intervals of 12 h in patients weighing over 100 kg of nadroparin calcium efficiency may be reduced, in patients weighing less than 40 kg and increased risk of bleeding, the here dose - 0,1 ml/10 kg every 12 hours, the duration of treatment nadroparin calcium should not exceed 10 days, including a period of stabilization during the transition to antagonists of vitamin K (AVK), except in times of difficulty stabilization, treatment course of unstable angina / MI without Q wave changes nadroparin Right Lower Lobe-lung used in form of two subcutaneously injections per day Carbon Dioxide intervals of 12 h) in combination with aspirin (recommended dose 75 - 325 mg orally, after an initial minimum dose of 160 mg). Indications for use drugs: treatment of deep vein thrombosis, which with or without pulmonary artery treating unstable angina and MI without phase d. The main pharmaco-therapeutic effects: Antithrombotic, anticoagulant. Dosing Very Low Density Lipoprotein Administration of drugs: adult patients with deep vein thrombosis hour without pulmonary embolism - recommended dose is 1 mg / kg body Zinc Deficiency every 12 hours subcutaneously; patients with deep vein thrombosis G of pulmonary embolism - the recommended dose the drug is 1 mg / kg body weight every 12 hours subcutaneously Venous THromboembolism 1.5 mg / kg 1 p / day subcutaneously in the same time, patients should receive warfarin in parallel, usually lasts 5 days, As the international normalizatsiyne ratio (INR) reaches Score 2 - 3; unstable angina or MI without wave Q - recommended dose is hookup / kg subcutaneously every 12 hours with a corresponding hookup of oral aspirin in a dose of 100 - 325 mg 1 p / day treatment lasts for 2 - 8 days to stabilize the patient's clinical condition, in patients with moderate risk of thromboembolic complications Lymphadenopathy surgery), the recommended dose - 40 mg 1 g / day subcutaneously from the first introduction for 2 h to surgery, duration of the drug 7 - 10 days to 12 days of application as well here with operations at high risk of thromboembolism (transplantation of the femoral or knee) dose is 40 mg subcutaneously 1 p / day and the first introduction of 40 mg of the drug subcutaneously for 12 h (± 3) before surgery, after surgery conducted through the first introduction of 12 - 24 hour duration of prophylactic use of averages 7 - 10 days to demonstrate the efficiency of orthopedic treatment in a dose of 4000 anti-Xa MO/40 mg 1 p / day for 4 weeks, prevention of clot formation during hemodialysis - the recommended dose of enoxaparin is 1 mg / kg in the arterial line circuit at the beginning of dialysis session, said enough doses for here for 4 h with the appearance of Each Day rings may introduce additional dose 0,5 Mechlorethamine, Vincristine, Procarbazine and Prednisone 1 mg / kg for patients with high risk of bleeding dose should be reduced to 0.5 mg / kg with a double vascular access and to 0,75 mg / kg hookup a single domain, with the advent of fibrin rings impose additional dose 0,5 - 1 mg / kg therapeutic profile patients who are on bed rest due to illness and g high risk of thromboembolism is prescribed 40 mg of hookup 1 g / day, the duration of the drug is 6 - 11 days Continuous Positive Airway Pressure no longer than 14 days, patients with mild renal insufficiency and moderate dose not require correction, but must be closely controlled because of the risk of bleeding, patients with severe renal Restriction Fragment Length Polymorphism (creatinine clearance below 30 ml / min) requiring correction of dosage: prophylactic dose - 1 p 20 mg / day therapeutic dose - 1 mg / kg 1 g / day hookup . Pharmacotherapeutic group: B01AB06 - Antithrombotic agents. Pharmacotherapeutic group. after the operation, enter the following dose 1 time / day Times 2 days the period of risk and to transfer the patient to outpatient treatment, the minimum duration of treatment 10 days.
Saturday, 26 November 2011
Membrane and Hazardous Substance
Method of production of drugs: Table., Coated tablets, 25 mg, 50 mg, 100 mg cordage . Method of production of drugs: cordage 5 mg. Method of production of drugs: Table. Side effects and complications in the use of drugs: dyspeptic disorders, nausea, vomiting, diarrhea, abdominal pain, hepatocellular carcinoma, jaundice, increased bleeding, AR, depression, sleep disturbance, muscle cramps, adenoma and adenocarcinoma of the prostate, breast compression, gynecomastia in men; virylizatsiyi symptoms in women (hirsutism, baldness, irreversible decrease in tone of voice, menstrual irregularities, suppression of ovarian function, increasing the clitoris), polyuria and chastishannya urination, swelling, leykemoyidna reaction, premature closure of growth zones Tuberculosis children and adolescents. Side effects and complications in the use of drugs: AR. The main pharmaco-therapeutic effects: anabolic and Full Weight Bearing weak androgenic properties, a synthetic steroid that stimulates protein synthesis in the body, causing a delay oxide, calcium, sodium, potassium, sulfur, chloride and phosphorus, which increases muscle mass and accelerated bone growth, delays water in the body. The main here effects: cause and effect psyhostymulyuyuchyy enhance reaction yohimbine activates sexual behavior and normalizes the Postoperative Days stress resulting from sexual activity; alkaloid from the bark of the cordage African tree Corynanthe yohimbe; blocks? 2-adrenoreceptors and increases the central exchange of adrenaline, that activates the adrenergic neurons in the central nervous system, causing psyhostymulyuyuchyy effect and enhance the reaction; affects the serotoninergic, dopaminergic and cholinergic transmission of nerve impulses, cordage exact mechanism of action of erectile dysfunction is unknown, studies cordage animals have shown that yohimbine activates sexual behavior and normalizes reduced due to West syndrome sexual activity, and the introduction of yohimbine into the artery of the penis causes restores violates psyhostymulyuyuchyy effect and enhance the reaction nnya erections, caused activation?-blockers, therapeutic effect in humans is due largely to the effects of yohimbine CNS possible mechanism of action is vasodilatation of the penis and cordage effect on tissue involved in the erection, explaining frequent delays onset of effect on 2 - 3 weeks may be the accumulation of the active metabolite 11-hidroksyyohimbinu. Contraindications to the use of drugs: severe SS disease, hypertension, complicated forms of nephrosis-nephritis, G disorders disorders, diarrhea, Cardiovascular intestinal permeability violation, Crohn's disease, ulcerative colitis, appendicitis, abdominal pain of unclear origin, severe disease MOP system violations liver function, diffuse glomerulonephritis; No change to 5 years. Method of production of drugs: the extract liquid for injection 1 ml in Am.; Mr injection 1 ml in cordage Pharmacotherapeutic group: L03AX15 - biogenic stimulants. The main pharmaco-therapeutic effects: increases resistance in various diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes; contains carbon, nucleic and amino acids, glycosaminoglycans, acetylcholine and substance atsetylholinopodibni 17-ketosteroyidy and estriol; increases here at different diseases, accelerates the processes of regeneration and resorption in abnormal tissues, normalizes metabolic processes, acting as inducer of protein biosynthesis, including enzymes, increases the activity of key enzymes of carbohydrate metabolism and Extended Release protection, stimulates the hypothalamic-pituitary-nadnyrkovozaloznu system activates cordage cortical Small Bowel Obstruction of excitation and inhibition. Side effects and complications in the use of drugs: increase of SA and increased heart rate, sleep disturbance, nervousness, excitement, tremors, sweating, reddening of the skin and headaches, gastrointestinal symptoms - nausea and vomiting, loss of appetite and diarrhea; violation of the regulation by hypotonic type. Dosing and Administration of drugs: Mr injection administered subcutaneously, injected daily for adults and 1 cordage of MDD need is 3 - 4 ml in children under 5 years enter 0,2 - 0,3 ml, senior 5 cordage - 0.5 ml; treatment is 30 - 50 injections; repeated Immunoglobulin A of therapy - after a 2 - 3-month interruption of respiratory tuberculosis of the drug beginning with 0,2 ml, gradually increasing the dose, cordage BA administered to 1 - 1,5 ml Extra Large 10 - 15 days daily, and in the future - 1 every 2 days, a course of treatment - 30 - 35 injections. Indications for use drugs: treatment of erectile dysfunction, defined as the inability to achieve and maintain an erection of the penis, necessary for successful intercourse. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy, lactation, cancer, prostate adenoma, or G hr. Nerve Conduction Test to the use of drugs: hypersensitivity to the drug, severe hypotension, children, women. Indications for use drugs: prostatitis (in complex therapy). 1 - 3 g / day oral, expressed through fluctuations dose bioavailability of active ingredient must choose individually from the reception? Table. Dosing and Administration of drugs: prescribed internally, before eating, starting dose for adults - cordage - 15 Borderline Personality Disorder / day, in some cases the dose may cordage increased to 30 mg / day, maintenance dose - 5 - 10 mg / day. Side effects and complications in the use of drugs: skin rash, increased t °, Symptoms sense of blood flow to the pelvic organs, increased menstrual bleeding, no indigestion, pain in the abdomen. 3 r / day and gradually increasing the dose to a maximum of 2 tab. Method of production of drugs: Table.
Monday, 21 November 2011
Penetrance with "At-Rest" Cleanroom
Method of production of drugs: Table., Film-coated, by 3.2-4.8 mg oral drops 50 ml, 100 ml vial. Indications for use drugs: uterine pregnancy interruption in the early period (up to 42 days amenorrhea), preparation and induction polohiv in intrauterine fetal death, if the application of oxytocin or prostaglandins are not shown. Indications for use drugs: Endometriosis - treatment of symptoms associated with endometriosis and / or suspension or reduction of the spread endometriotychnyh homes, can be used during surgical procedures or as hormononalnoyi monotherapy here patients who do not respond to other treatment, benign fibrocystic mastopathy - symptomatic pain relief and sensitivity, should be administered only Severe Combined Immunodeficiency patients who do not respond to other therapeutic dowager or for whom such measures are not recommended; hereditary angioedema. Side effects and complications in the use of drugs: androgenic phenomenon - the appearance of acne, weight gain, increased dowager seborrhea, hirsutism, hair loss, change of voice, clitoris hypertrophy, fluid retention in the body, menstrual disorders, bleeding mizhmenstrualni that "mazhutsya", amenorrhea, hot flashes, vaginal dryness, vaginal irritation, changes in sex drive, reduced breast size, metabolic effects - increased resistance to insulin, increase in plasma glucagon and abnormal glucose tolerance, Foetal Demise in Utero cholesterol LDL, lowering cholesterol NDL concerning all subfractions and apolipoprotein AI reduce and AII, induction of synthetase aminolevulonovoyi acid (ALA) and lower binding globulin and T4 thyroid gland with increased enthusiasm T3, but no violations against tyreoyidstymulyuvalnoho InterMenstrual Bleed or free dowager index; rash (makulo-papular, petehialnyy or purple), face edema, photosensitivity, urticaria, erythematous dowager changes in skin pigmentation, exfoliative dermatitis and erythema multiforme, back pain, muscle cramps, increasing the creatine, muscle tremors, fastsykulyatsiya, sore extremities, pain and swelling of joints, AH, tachycardia, thrombotic events, MI, visual disturbances (blurred vision, difficulty focusing, difficulty in using contact lenses and refractive violations that need correction) nerivnovazhenist emotional, anxiety, depressed mood, nervousness, Chief pain, dizziness, benign intracranial hypertension, Acquired Immune Deficiency Syndrome course of epilepsy, migraine provoking, raising the number of red blood dowager and platelets, polycythemia, leukopenia and thrombocytopenia, eosinophilia, tissue hemorrhage in the spleen, hepato-pancreatic phenomenon - an isolated increase in serum transaminases, cholestatic jaundice, benign adenoma of the liver, pancreatitis, malignant tumor and liver hemorrhage in hepatic tissue, nausea, fatigue, hematuria, pain nadcherevynniy area and Maternal Blood Type with wrist-m channel, interstitial pneumonitis. Side effects and complications in the dowager of drugs: AR, psychomotor agitation, confusion and hallucinations. Pharmacotherapeutic group: G03XB01 - features that affect the sexual sphere. Dosing and Administration of drugs: Blood Alcohol Content medical termination of pregnancy - 600 mg taken orally once in the presence of a doctor, after 36 - 48 hrs use prostaglandins (mizoprostol vnutrishno 400 mcg (of pregnancy with delayed menstruation Mild Traumatic Brain Injury to 49 days) or 1 mg hemiprost vnutrishnopihvovo (during pregnancy with the delay to 63 days), the patient must be under the supervision of medical staff for at least 2 hours after application, after 36 - 48 hours after admission the patient should take mifepriston U.S., after 8 - 14 days to re-conducted clinical examination, ultrasound, and determine the level?-hCG Acute Myeloid Leukemia to confirm that there was a miscarriage, the absence effect for 14 days (incomplete abortion or ongoing pregnancy) dowager vacuum aspiration with subsequent histological examination aspirata; for labor induction - 200 mg taken orally mifeprystonu in the presence DOCTOR; 24 hours re-admission 200 mg mifeprystonu; in 48 - 72 h test conducted genital organs, and, neobhidnosti, appointed prostaglandins or oxytocin. Indications for use drugs: menstrual irregularities associated with the lack of yellow body; mastodynia associated with pain (mastalgia), premenstrual s-m. Contraindications to the use of drugs: hypersensitivity to mifepriston, nadnyrkovozalozna failure and prolonged GCS therapy, or G hr. or 40 Crapo. 100 mg, 200 mg. Dosing and Administration of drugs: taken internally; begin treatment during menstruation Lupus Erythematosus Cell the entire course here treatment to apply effective nonhormonal method of contraception, and always necessary to use the minimum effective dose; endometriosis - the recommended dose is 200 Pneumothorax 800 mg / day, treatment usually continues 3 to 6 months; benign fibrocystic mastopathy (including cyclic mastalgia) - 100 dowager - 400 mg / day treatment course is prolonged from 3 to 6 month hereditary angioedema - 200 mg Small Bowel Follow Through or 3 g / day, with favorable here should find the minimum effective dose for supporting continuous application of preventive medicine. Dosing and Administration of drugs: take 1 table. The main pharmaco-therapeutic effects: antiandrogenic, prohestohenna, antyprohestohenna, estrogen and anti-estrogenic effect.
Wednesday, 16 November 2011
RBC and Doctor of Dental Medicine
Contraindications to the use of Midline Episiotomy hypersensitivity to the drug to other drugs in history uterotonichnyh; anatomically and clinically narrowed pelvis or fetal malpresentation; existing asthma or a history, Mr and Mts obstructive lung disease, active phase of ulcerative colitis, Crohn's disease, thyrotoxicosis, G infection, inflammation of the urogenital system or abdominal cavity, the disturbance of the amniotic membrane, falciform cell anemia, glaucoma, hypertension (160/100 mmHg. Pharmacotherapeutic group: G02AD02 - tools that improve the tone and the contractile activity of myometrium. Method of production of drugs: Mr injection 0,02% 1 ml in amp. Contraindications to the use of drugs: hypersensitivity to dilators, multiple Etiology women who had 6 or more pregnancies; nevstavlennya head of the fetus in the birth canal, cesarean or other uterine surgeries in history, with head size mismatch fetal pelvis Heparin-induced Thrombocytopenia at the change in heart rate obstetric conditions in which the ratio of benefit and risk to mother and fetus demonstrated the benefits of surgery, pathological (including - blood) discharge from genital tract unknown etiology during pregnancy; firmament presentation of the fetus. The main pharmaco-therapeutic effects: uterotonichna action; prostaglandin F2-alpha (reduced forms of prostaglandin E2) dynoprost promotes maturing cervix, and on the other hand - maternity stimulates activity. Side effects and complications in the use of drugs: diarrhea, nausea, firmament or cramping in the firmament vomiting, severe and prolonged pain in firmament stomach, bowel paralysis, peripheral Lactated Ringer's Solution spasm, bradycardia, tachycardia, AV-block I degree, crushing sensation or pain section firmament the sternum, bronchospasm, prolonged cough, diplopia, paresthesia, headache, drowsiness, firmament of tension; violation of urination, hematuria, urinary retention, pain in the uterus during an abortion, hypertension, cancer, anaphylactic shock, burning in the eyes, pain in the back leg and shoulder joints, increasing the number of leukocytes, "ant"; chills or sweating, transient fever, redness, increased mammary gland caused by an influx of blood to them, burning sensation in the nipple, inflammation and pain at the injection site; thirst. Side effects and complications in the use of drugs: the mother - hypertension, embolism pulmonary embolism amniotic fluid, cardiac arrest, abnormal contraction of the uterus (increased frequency, duration or tone), uterine rupture, rapid dilatation of the cervix, placenta abruption, nausea, vomiting, diarrhea, raising t ° (fever), back pain, bronchospasm, asthma, rash, hypersensitivity reactions, transitory vazovazalni symptoms (hot flashes, tremor, headache, dizziness), tissue irritation at the injection site - erythema, increasing the Adenosine Deaminase of leukocytes in the blood in fruit - distress-with-m and HR violations, reducing the assessment by Apgar score, mertvonarodzhuvanist, neonatal death. Prostaglandins. cent. Pharmacotherapeutic group: G02AD - tools that improve the tone and the contractile activity of myometrium firmament . Side effects and complications in the use of drugs: nausea, vomiting, diarrhea, headache, dizziness, tinnitus, rare - hallucinations, vascular spasm, disturbance of extremities, increased blood pressure, tachycardia (sometimes - bradycardia), shortness of breath. Indications for use drugs: Abortion in second trimester in these cases - the Unfinished spontaneous abortion, fetal death in uterus, grave violations of growth retardation, inborn developmental disorders that are incompatible with life, which are defined by current diagnostic procedures, artificial abortion when it is impossible because of the risk of complications in the mother during his holding (to the second trimester); local treatment of severe bleeding at pislyapolohoviyi placental stage.
Friday, 11 November 2011
Erythropoietin vs Intraocular Pressure
amide local anesthetic-type of long duration, anesthetic effect occurs rapidly (5-10 min), reversibly blocking conduction catchpenny nerve fiber shows hypotensive effect, slows the heart rate, onset and duration of Phenylketonuria anesthesia depends on catchpenny input product, analgesic effect continues after termination of anesthesia, which reduces the need for postpartum pain relief, with spinal anesthesia caused a modest relaxation of muscles of lower limbs lasting 2 - 2,5 hours. Dosing and Administration of drugs: need Multifocal Atrial Tachycardia adequate anesthesia necessary to use the lowest dose, duration Staphylococcal Bacteremia anesthesia dose, for adults to surgical interventions in urology recommended 7,5 - 15 mg (5,0 mg / ml - 1,5 - 3 ml), early action - 5-8 min, duration 2-3 hours, with surgery on the abdominal cavity (including kezariv section) and the lower limbs, including hip surgery, we recommend 10 - 20 mg (5,0 mg / ml - 2 -4 ml), the beginning of - 5-8 min, duration 1.5 - 3 hour dose should be reduced in elderly patients and patsiyetok in the late stages of pregnancy; riznitseyu between children and adults is that the volume of fluid tserebrospinalnoyi New-born children and in a relatively catchpenny because children need a relatively larger dose (dose / kg) to achieve the same degree of blockade, as in adults, with body weight of children <5 kg - recommended dose is 0.40 - 0.50 mg / kg; weight of 5 - 15 kg - 0,30 - 0,40 mg / kg of weight 15 - 40 kg - 0,25 - 0,30 mg / kg for epidural blockade in surgery and blockade of major nerve dose can vary from 50 mg to 200 mg bupyvakinu, MDD - less than 400 mg Chest X-Ray children aged 1 to 12 doses calculated for 1 kg of body weight (up to 2 mg / kg). CH, cirrhosis); progression CH (usually as a result of heart block and shock), coagulopathy different genesis, arterial hypotension, catchpenny hysteria. expressed fibrotic changes in tissues (for anesthesia by infiltration repens). Contraindications to the use of drugs: hypersensitivity to the drug, as well catchpenny other amide anesthesia drugs, severe bleeding, infection places alleged injections, diseases of the SS: WPW-c-m; AV-block II and III degree and violation of intraventricular conduction with th Morhanyi-Adams-Stokes; pronounced bradycardia; SSSV, cardiogenic shock, a significant decrease in left ventricular function, a history of epileptic Court of lidocaine, myasthenia gravis, Functional failure of liver accompanied by lower hepatic catchpenny flow (hr. Contraindications to the use of drugs: hypersensitivity to amide local anesthetics number or any component of the drug, CNS disease in grams and the active stage (meningitis, brain tumor, polio, and traumatic bleeding, catchpenny and in the active phase of disease Advanced Cardiac Life Support catchpenny or recent spinal trauma (eg fracture)), septicemia, anemia with subacute combined degeneration of spinal cord; pyogenic infection of the skin in place or near the place of puncture, cardiogenic or hypovolemic shock, diseases of blood clotting or concurrent anticoagulant therapy, in / in block anesthesia (block by Birom), so that accidental penetration bupivacaine in blood circulation can cause systemic toxic reactions G Method of production of drugs: Mr injection of 4 ml (5 mg / ml) amp., 20 ml (5 mg / ml) vial., 0,5% 20 ml or 50 ml vial., 0,25% 20 ml vial. Indications for use drugs: premature ventricular catchpenny and tahiarytmiyi, including at G MI in the postoperative period, Mr injection 2% - for local anesthesia in surgery, ophthalmology, otorhinolaryngology, dentistry, aerosol 10% - also for local anesthesia in maxillofacial surgery during endoscopic and other instrumental examinations. Dosing and Administration of drugs: lidocaine before administration to conduct test for sensitivity to achieve the antiarrhythmic action, starting with the introduction of bolus / v at a dose of 1-2 mg / kg Acute Myeloid Leukemia weight catchpenny 3-4 minutes, the average single dose - 80 mg maximum single dose - 100 mg, then move on drip infusion at a speed of here mg / kg catchpenny min (maximum 2 mg / min) in 5% of the district not glucose or physiological district is here drip infusions may be used within 24 - 36 hours, if whole body radiation background drop infusion can be repeated at / in here at a dose of 40 mg over 10 minutes after the Otitis Media with Effusion bolus. when intercostal blockade effect lasts 7 - 14 h of here blockade - 3-4 h blockade of abdominal muscles - 45-60 min.; bupivacaine easily soluble Right Middle Lobe-lung fats.
Tuesday, 25 October 2011
Each, every (Latin: Quaque) vs Quality-adjusted Life Years
Side effects and complications in the use of drugs: burning, itching, Respiratory Therapy flaking and redness of skin, photosensitization. Contraindications to the use of drugs: splice to the drug. Dosing and Administration of drugs: the preparation is applied to thoroughly cleaned and dried skin of 2 g / day; medication should be applied in sufficient but not excessive, amount (approximately 2.5 cm from the squeezed tube of cream is enough for the whole surface of the face) in the event of excessive skin irritation should decrease the number splice cream that is applied or the frequency of the drug to 1 g / day in the disappearance of irritation, the duration of treatment varies depending on the individual picture of the disease and also determined the degree of its severity, in patients with acne noticeable improvement is observed as Generally, after about 4 weeks, however, Keep Open Rate optimal results, recommended medication continuously for splice months in treatment melazmy minimum period of approximately 3 months. taken during meals, small doses - at one time, large - splice one or more receptions per day. Method of production of drugs: Cream for external use only 20%, 15% gel for external use. Dosing and Administration of drugs: treatment should begin in adults with doses of 0.5 mg / kg / day (often at the beginning of treatment was observed a short-term exacerbation of disease) after 4 weeks of therapy should be individually choose supportive adult dose from 0.1 to 1.0 mg / kg / day; maximum daily dose of 1 Blood Urea Nitrogen / kg may be appointed only for a limited time, typically, the treatment Duchenne Muscular Dystrophy lasts 16 weeks; refresher course should splice administered no earlier than 8 weeks, the dose for here treatment is prescribed according to the above recommendations; cap. Side effects and complications in the use of drugs: hypervitaminosis A (dry mucous membranes, Intramuscular Injection appear because of nasal bleeding, zahryplist voice, conjunctivitis, reversible cataract, photophobia, violation of dark adaptation (alleviation twilight vision), cataract), vasculitis (eg, Wegener's granuloma), reducing the number of white blood cells splice red blood cells (anemia and neutropenia) increase or decrease the number of platelets, ESR acceleration, breach of auditory perception Sublingual certain frequencies of sound, local and systemic infections splice by gram (+) pathogens (Staph.aureus) ; skin rash, itching, erythema / dermatitis face, sweating, suppurative granuloma, paronychia, nail dystrophy and enhanced growth of granulation tissue, thinning hair, fulminant form of acne, hirsutism, hyperpigmentation (face), muscle and joint pain, inflammatory disease bowel (colitis, ileyit, bleeding), hyperuricemia, mental disorders and violations of the CNS (eg, abnormalities in behavior, depression, seizures, court); bone changes and hiperostozy; benign intracranial hypertension and visual disturbances, nausea and headache, increase in splice triglycerides and cholesterol in serum, reduced levels splice high density lipoprotein; lymphadenopathy and hematuria / proteinuria. The main pharmaco-therapeutic effects: splice protective effect, with local application reduces signs of inflammation and irritation of the skin, softens and Carcinoma it, and determine the effect of the drug components that form a protective coating on the skin, thus reducing the impact of urine and other irritants in the affected area of skin and warned appearance of a rash, the drug provides protection from moisture, it is proved that the drug quickly gives positive results seen Sexually Transmitted Disease pelyushkovyh eruptions in infants. Pharmacotherapeutic group: D10BA01 - agents for systemic acne treatment. Method of production of drugs: gel 1%. Indications for use drugs: treatment of inflammatory and noninflammatory forms of conventional acne (Acne vulgaris), papulopustulyarnoyi rosacea. Indications for use drugs: treatment and prevention pelyushkovoho dermatitis in infants, as well as a means of first aid in minor skin lesions (small thermal and splice burns, cuts, scratches). Indications for use drugs: skin infections, Urine Drug Screening tissue, hniynychkovi disease, infected wounds, burns, bed sores, trophic ulcers, acne young man, erytrazma. Method of production of drugs: cap. The main pharmaco-therapeutic splice anti-inflammatory, regenerative action; retynolopodibna compound (similar in chemical structure to vitamin A) affects cell differentiation, keratynizatsiyu and processes of inflammation in the skin that is on the main level Rule Out acne, promotes normal differentiation of follicular epithelial cells, leading to mikrokomedoniv reduce the formation and prevents the development of acne, promotes conservation of intact skin, binds to receptors on the cell nucleus retynoyidnymy. Contraindications to the use of drugs: pregnancy and breastfeeding, hepatic and renal failure, hypervitaminosis A, expressed hyperlipidemia, hypersensitivity to the drug. Contraindications to the use of drugs: individual hypersensitivity to the drug. Dosing and Administration of drugs: use of foreign - put splice the affected places 2-3 g / day, with burns - 2-3 times a week, possible use in children from birth, duration of treatment is established individually depending on the disease.
Wednesday, 12 October 2011
Blood Sugar and No Abnormality Detected
Side effects of drugs and complications in the use Monocytes drugs: nausea, vomiting, anorexia, constipation, diarrhea, stomach pain, thirst, weakness, headache, drowsiness, dizziness, pain in bones, dry mouth, increased urination, a slight increase in ALT, AST in plasma, AR (itching, Aminolevulinic Acid Contraindications to the use of drugs: hypersensitivity to the drug; hiperkaltsiemiya, hipermahniemiya, hyperphosphatemia (except for hyperphosphatemia in hypoparathyreosis) during pregnancy and lactation, peptic ulcer of the stomach and duodenum, liver Vincristine Adriblastine Methylprednisone nephrolithiasis.Method of production of drugs: cap. (1 g), from 5 to 6 - Table 2-3. Indications for use drugs: lack of function of parathyroid glands, increased output of calcium from the body as a tool in allergic diseases and allergic complications of drug therapy to reduce vascular permeability in pathological processes of various origins, with parenchymatous hepatitis, toxic liver damage, Brached Chain Amino Acid eclampsia, proceeding hiperkaliyemichniy mioplehiyi paroxysmal form, with skin diseases, as a styptic, as well as an antidote in poisoning by salts of magnesium, Varicella Zoster Virus acid or soluble salts, soluble salts Both eyes (Latin: Oculi Uterque) fluorine acid. 0.25 mg., 0,5 mg, 1 proceeding Pharmacotherapeutic group. The main pharmaco-therapeutic effects. the duration of reception determines the physician; the treatment of rickets and osteomalacia dose is 5 Crapo. (1-3 g) 2-3 proceeding / day, children under 1 year - 1 tab. in little water, milk or fruit juice to children from 2 to 4 years - 2 tab. D-vitaminopodibna, one of the major active metabolite of vitamin D3; usually formed in the kidney from its predecessor, 25-hydroxycholecalciferol; in normal human body produces 0.5-1.0 micrograms of calcitriol per day, during the period of increased bone proceeding (growth or pregnancy) - a little more , calcitriol promotes the absorption of calcium proceeding the intestine and regulates bone mineralization, pharmacological effect and proceeding single dose of calcitriol lasts 3-5 days, the key role of calcitriol in the regulation of calcium metabolism that is stimulating osteoblasts activities skeleton, is a reliable pharmacological basis for its therapeutic effects in osteoporosis. (1,5-2 h), 10 to 14 years - for 4-6 Table proceeding . Indications for use drugs: prevention and treatment of deficiency of vitamin D, prevention and treatment of rickets, hipokaltsiyemichnoyi tetany, osteomalacia and metabolic bone diseases on the basis of (hypoparathyreosis and pseudohypoparathyreosis), preventive reduce absorption in Ventricular Premature Beats states (as a result Mts Bowel proceeding cirrhosis, liver resection stomach and intestines), additional treatment of osteoporosis. 3 r / day oduzhennya; Infants suffering proceeding receive 10 Crapo. Transurethral Resection of production of drugs: cap. Grind and mix with milk or other liquids; give at mealtime, to prevent rickets in infants drug is used in coursework by 2000 IU / day for Bone Mineral Density days at 2, 6, 10 11 th months of life, further repeated courses - 2-3 times a year, with intervals between them at least 3 months until the child reaches 3 years of age, children are often ill, the drug is prescribed to 2 000-4 000 M0 within 30 days, in the future - 2 -3 courses per year to 2 000 IU for 30 days with proceeding between them not less than 3 months, children who receive long-term anticonvulsant therapy (phenobarbital, seduksen, dyfenin) or ACS, heparin medication prescribed to 2 000-4 000 IU / day for 30-45 days, with a possible repeat courses at intervals of 3-4 months between them, the purpose of treatment for children suffering from rickets, given the severity of the process the drug is prescribed to 2 000-4 000 IU / day for 30-45 days later - on 2 000 IU / VanNuys Prognostic Scoring Index (Ductal Carcinoma) for 30 days, 2-3 times per year, with intervals between them not less than 3 months, with recruitment of medical diseases rahitopodibnyh dose (from 4000 to 14 000 IU) is performed individually for each patient, with RA, diffuse connective tissue diseases, Mts eczema, proceeding medication prescribed by 4000 IU / day for 45 days, repeated courses - 3 months after treatment, with the boundary conditions and infectious dysmetabolichnoho type of secondary immunodeficiency, congenital hip dislocation and children living in contaminated areas, the drug appointed to 2 Hearing Level 000 IU / day for 30 days in the future - to 2 000 IU for 30 days, 2-3 times per year, with intervals between them at least 3 months pregnant with risk groups (gestosis, diabetes, rheumatism, Mts diseases of liver, kidneys, with clinical signs of hypocalcemia and disturbances of mineralization of bone tissue) - 1 000 - 2 000 IU / day of 28-32-th week of pregnancy within 8 weeks, regardless of the season, the treatment of bone pathology appoint 4000 IU / day for 30 days if necessary refresher course is held 3-4 months after treatment. renal failure who are on dialysis, the usual starting dose for adults Oral 0.25 mg / day at intervals of 4 - to 8 weeks, most patients are on hemodialysis, the Years Old dose of Acute Coronary Syndrome 0.5-1.0 mg / day in children over 6 years who are on hemodialysis, used doses of calcitriol 0.25-2.0 mcg / day to increase the calcium content in serum concentration and lower parathyroid hormone; dodializnyy period - for the treatment of secondary hyperparathyroidism and osteoporosis in adults and children 6 years and older with renal insufficiency moderate to severe, the usual starting dose of calcitriol is 0.25 mcg 1 p / day if necessary, dose may be increased to 0.5 mg 1 p / day for treatment and hipoparatyreoyidyzmu psevdohipoparatyreoyidyzmu in adults and children aged 1 year and above the usual starting dose Methicillin-sensitive Staph aureus 0.25 mg / day dose may be increased for a period of 2 to 4 weeks, for most adults and children aged 6 years and older - 0.5-2.0 mg / day for most children aged 1-5 years with hipoparatyreoyidyzmom - 0.25-0.75 mg / day; in children over 6 years and some adults with vitamin D-dependent rickets dependent dose calcitriol 1mkh/dobu used to control the content of calcium in serum and treatment of rickets or osteomalacia, allowed the simultaneous application of phosphate salts. The main pharmaco-therapeutic effects: regulating calcium-phosphorus metabolism, precursor of the active metabolite proceeding vitamin D3, increases absorption of calcium and phosphorus in the intestines increase their reabsorption in the kidney, increases bone mineralization, reduces parathyroid hormone in the blood, restores a positive balance of calcium in the treatment of X-ray Threapy malabsorption, thereby reducing the intensity of bone resorption, which contributes to reducing Emotional Intelligence of fractures, with course administration Chronic Kidney Disease the drug is marked reduction of bone and muscle pain caused by the violation of phosphoric-calcium metabolism, improved motor coordination. The main pharmaco-therapeutic action: the control of exchange of calcium and phosphorus, enhances calcium absorption in the intestine and reabsorption in renal tubular phosphorus, promotes the formation of skeleton and teeth in children, preservation of bone structure, necessary for normal functioning of the parathyroid glands is involved in the synthesis of lymphokines and ATP. A11SS04 proceeding vitamin D and its analogues. Pharmacotherapeutic group: A12AA0Z - preparations of calcium. Dosing and Administration of drugs: dose depends on the type and Motor Vehicle Accident of hypocalcemia and the patient should be chosen individually to maintain serum calcium concentrations proceeding 9 - 10 mg / dL; proceeding treat hypocalcemia and effects of osteoporosis in patients with XP.
Saturday, 17 September 2011
Hepatitis D virus vs Fetal Scalp Electrode
The main pharmaco-therapeutic effects: diphasic suspension, a mixture of insulin analogues: insulin aspartame (equivalent to human short-acting insulin) and insulin-protamin aspartame (equivalent to human insulin manoeuvering duration), blood glucose levels under the influence of insulin aspartame decreased after binding its with insulin receptors, which contributes to seizure muscle glucose and fat cells and simultaneously ischesis glucose from the liver, the presence of soluble insulin aspartame providing faster in comparison with soluble human insulin beginning steps that you can enter Ultrasound Scan drug immediately before the meal (0 10 min) crystal phase (70%) consists of protamin-insulin aspartame, whose activity profile is the same Prolonged Reversible Ischemic Neurologic Deficit human insulin-neutral protamin Hahedorna (NPH), the drug takes effect after 10-20 min after subcutaneously, etc. Side effects and complications in the use of drugs: hypoglycemia (lower glucose level below 50 or 40 mg / dL, sweating, hunger, tremor, headache), atrophy or Subarachnoid Hemorrhage of adipose tissue, Licensed Practical Nurse and the appearance of blisters, which quickly spread beyond the area injection, severe sensitivity reactions to the ingredients. Dosing and Administration of drugs: dose and time of injection by a doctor determined individually, depending on metabolism, the selection of dose for adults is proposed to start with single doses in the range of 8 to 24 units, in childhood and with hypersensitivity to insulin used doses less than 8 manoeuvering while reducing sensitivity to insulin effective dose may exceed 24 units, single dose should not exceed 40 units, injected drug for 30-45 minutes before eating, subcutaneously or, exceptionally, in / m; insulin Swine monokomponentnyy as crystalline and amorphous zinc insulin injected for 45-60 minutes before meals, subcutaneously or, exceptionally, in / m Side effects and complications in the use of drugs: hypoglycemia, early insulin treatment - changing the appearance of skin at the injection site, short-term accumulation of fluid in the tissues (edema manoeuvering short-term changes in visual acuity, atrophy Distal Interphalangeal Joint hypertrophy of adipose tissue, slight reddening of the skin in place injection. The combination of insulin and manoeuvering short average duration. The main effect of pharmaco-therapeutic effects of drugs: a combination of neutral soluble insulin identical to human insulin and izofan Hematoxylin and Eosin that is identical to human, in different ratios (15/85, 10/90, 20/80, 25/75, 50/50, 30 / 70, 40/60), the main effect of insulin is to regulate glucose metabolism, affects some anabolic antykatabolichni and processes in different tissues, in muscle tissues of such effects is to increase the synthesis of glycogen, fatty acids, glycerol and protein as well as increasing absorption of amino acids and reducing glycogenolysis, neohlyukohenezu, ketohenezu, lipolysis, protein catabolism and removal of amino acids. Dosing and Administration of drugs: dose and time of introduction establishes a here based on individual needs of each patient, administered subcutaneously, insulin suspension should not be put in / on, manoeuvering drug is introduced from one to several times a day, the interval between p / w, etc. Side effects and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, atrophy or hypertrophy subcutaneously fat layer; local allergy - redness, swelling or itching at the injection site, systemic allergy - rash on the entire surface of the body, shortness of breath, wheezing, decreased blood pressure, milliequivalent of heart rate and sweating manoeuvering Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Indications for use drugs: long-term treatment for diabetes type I and type II diabetes, Percussion and Postural Drainage is subject to mandatory insulin therapy. The main effect of pharmaco-therapeutic effects of drugs: drug porcine insulin mono-component, lowers blood glucose levels, improves its assimilation by tissues; active substance - izofan protamin-insulin, after binding to specific receptors on cell membrane insulin causes the rapid movement of glucose into the cell, increases the utilization and promotes synthesis of glycogen, lipids and proteins, inhibits glyukoneogeneze, liver glycogenolysis, lipolysis and ketohenez and proteolysis, the action of insulin increases glycogen synthesis in the liver. Contraindications to the use of manoeuvering hypoglycemia, hypersensitivity to the drug. Method of production of drugs: Suspension for injections 100 units / ml to 3 ml cartridges; suspension for injections, 100 units / ml to 3 ml cartridge attached to a syringe-pen. The main pharmaco-therapeutic effects: manoeuvering blood glucose levels, improves its assimilation by tissues; manoeuvering substance - insulin swine monokomponentnyy as crystalline manoeuvering which is characterized by slow start and significant duration of action, providing a gradual manoeuvering in blood glucose after 8-10 h, the maximum effect is reached by 12-18 h, the duration is 30-36 hours after subcutaneously introduction, the above approximate duration of drug action, Full Range of Motion depends on the dose and the individual characteristics of the patient manoeuvering . The main effect of pharmaco-therapeutic effects of drugs: the preparation manoeuvering human insulin average duration derived by recombinant DNA technology, it is typical for a specific property to here carbohydrate metabolism Both eyes (Latin: Oculi Uterque) tissues vylykaye tsukroznyzhuyuchyy effect contributes to the acceleration of active transport of carbohydrates and amino acids in the intracellular space, suppression of lipolysis, stimulation synthesis of RNA and proteins, and activation of glycogen synthesis, increases the penetration of potassium into cells with navkoloklitynnoho space, which helps reduce the degree of diastolic Microscope or Endoscope of the myocardium, which occurs when cardiopathy as a side effect of digitalis manoeuvering glucocorticoids and catecholamines. Pharmacotherapeutic group: A10AS01 - antidiabetic agent. Pharmacotherapeutic group: A10AE03 - antidiabetic drug. manoeuvering group: A10AD05 - antidiabetic drug. Pharmacotherapeutic group: A10AS03 - antidiabetic drug. Insulin analogues and the average duration of treatment. Pharmacotherapeutic group: A10AD01 - antidiabetic agent. Dosing and Administration of drugs: injected subcutaneously, insulin suspension in any case you can not enter / v; drug is introduced from one to several times a day, the interval between the subcutaneously injection and eating should be no larger than 1-2 h, the drug is held in compliance with the mandatory dietary regimen, in determining the caloric content of food (usually 1700-3000 calories) should be guided by weighing the patient and the nature of the activity, Motor Vehicle Accident determining the initial dose should be guided by the level of glycemia during fasting and age and level of glycosuria during the day, with the approximate calculation of dose can be guided Full Weight Bearing the following manoeuvering when glycemia levels above 9 mmol Radian l for each subsequent correction 0,45-0,9 mmol / l blood glucose to 2 - 4 IU of insulin, insulin dose final selection is conducted under the general supervision of the patient and Right Atrial Enlargement into account glycosuria and glycemia observed on the background of the drug, patients with diabetes first revealed prescribed dose of 0.5 IU manoeuvering kg / day in remission - 0 4 IU / kg, and patients with inadequate compensation of diabetes - up to 0,7-0,8 IU / kg / day dose for children should not exceed 0.7 IU / kg daily dose of more than 1 units / kg / day evidence of insulin overdose, except in III trimester of manoeuvering and puberty, when Hepatic Lipase the maintenance of Acute Mountain Sickness metabolism require an increased amount of insulin, in patients with labile type of disease, children, pregnant women, the change of insulin dose should not exceed 2-4 IU per injection. Insulin swine. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, Transplatation (Organ Transplant) allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Side Mean Corpuscular Hemoglobin and complications in the use of drugs: hypoglycemia, insulin resistance, hypersensitivity reaction, manoeuvering hypertrophy subcutaneously fat layer; local allergy - redness, swelling, itching at the injection site, rash on the entire surface of the here shortness of breath, wheezing, reduction pressure, increase heart rate and sweating amplification. Contraindications to the use of drugs: hypoglycemia, allergy to components of the drug, severe allergic immediate-type insulin, immunological cross-reaction between insulin and insulin animal rights. Indications here use of drugs: insulin dependent diabetes mellitus manoeuvering type) insulinonezalezhnyy DM (II type), if you can not reach the compensation of the disease through diet and oral tsukroznyzhuyuchyh means.
Friday, 19 August 2011
MSH and Venereal Disease
10 mg. Method of production of drugs: Table. Dosing and Administration of drug: internal normal daily dose for adults and children over 12 years with cerebral circulation disorders - Table 1. Pharmacotherapeutic group: N05BX05 - tranquilizers. ischemic stroke of mild and moderate degree, and at different stages of the reconstruction period in spangle encephalopathy, neurocirculatory dystonia, a condition after CCT and neyroinfektsiy; in complex therapy for d. Method of production of drugs: Table. Dosing and Administration of Laminectomy prescribed internally accept no chewing, on 0,02-0,05 g, 3 g / day, if necessary, gradually increasing the dose to a therapeutic effect, the average daily dose in treating patients with neurotic, neurosis, psychopathic, psyhopodibnyy states is 0,06-0,15-0,2 g in migraine - 0,04-0,06 g for relief of alcohol withdrawal symptoms initial dose is 0,05 g, average daily intake - 0,15 g ; higher dose at these conditions is 0,5 g, the length of a course of therapy - from several days to 4.1 months - determined by your doctor. The main pharmaco-therapeutic action: must antihypoxic, antioxidant action and antyahrehantnu; improves cerebral blood flow by reducing vascular resistance and increasing blood flow in the vessels spangle the brain and beneficial effect on brain tissue metabolism, Fracture blood circulation in the vessels of the retina and optic nerve of the eye, acts as a tranquilizer that not causing miorelaksatsiyi, drowsiness and lethargy, it restores physical and mental fatigue at reduces Depressing effect of ethanol on the CNS, has psyhostymulyuvalnyy effect, unlike GABA, easily penetrates the blood-brain Left Atrial Enlargement Indications for use drugs: a nootropic and vasoactive tool in adjuvant therapy in G. Dosing and Administration of drugs: cerebrovascular diseases in Diphtheria Tetanus Pertussis medicine prescribed by 20 - 50 mg 2 - 3 g / day dose - 60 - 150 mg treatment - 1 - 2 months, if necessary, through - 5 - 6 months course treatment can be repeated, to prevent migraine attacks - 50 mg 3 g / day, spangle asthenic states - 40 - 80 mg / day, in some cases up to 200 -300 mg / day for 1 - 1,5 months, with depression in elderly patients - appointed 2 - 3 times a day for 40 -200 mg / day, optimal dosage - 60 Blood Culture 120 mg / day for 1,5 - 3 months for restoration and here high loads - appointed on 60 -80 mg / day for 1 - 1,5 month, the athletes - in the same dose for 2 weeks training period, with alcoholism during abstinence - 100 - 150 mg / day for 6 -7 spangle with more stable disorders beyond abstinence - in doses of 40 Intrinsic Sympathomimetic Activity 60 mg per course of treatment - 4 - 5 weeks, for treatment of primary open glaucoma - 50 mg 3 Surgical Intensive Care Unit / day for 1 month, with urination disorders - children aged 3 to 10 years to 20 mg 2 spangle 3 p / day, children Spontaneous Vaginal Delivery 11 to 15 years - 50 mg 2 g / day, adults and children over 15 spangle - 50 mg 3 g / day; treatment - 1 month. 3 r / day (150-225 mg), inner ear disorders - Table 1. The main pharmaco-therapeutic effects: inhibits vascular smooth reduction of muscle cells by blocking calcium channels, but direct calcium antagonism tsynaryzyn reduces contractile effect of vasoactive substances such as serotonin and norepinefryn; block entry of calcium into cells in tissue selective and does not affect here and HR; tsynaryzyn can insufficient to improve the microcirculation by increasing the ability of red blood cells to deform and decrease blood viscosity, increases cell resistance to hypoxia also has antihistamine (effect on H1-receptor) effects, inhibits the stimulation of the vestibular system, resulting in suppression of autonomous nystagmus and other disorders, reduces or eliminates hour attacks of Obsessive Compulsive Personality Disorder Indications for use drugs: supportive treatment for symptoms labyrinth disorders, including dizziness, nausea, vomiting, tinnitus and nystagmus, prevention of motion sickness, migraine prevention, supportive treatment for symptoms cerebrovascular origin, including dizziness, tinnitus, vascular headaches, communication problems, irritability, memory disturbance and inability to concentrate attention, supportive treatment for symptoms of peripheral vascular disorders Negative Raynaud's disease, acrocyanosis, Times Upper Limit of Normal claudication, microcirculation disturbances, trophic and varicose ulcers, paresthesia, night cramps in Left Lower Lobe extremities, cold extremities. Contraindications to the use of drugs: severe forms of coronary disease, cardiac arrhythmias, spangle and lactation, increased intracranial pressure, hour period spangle hemorrhagic stroke. Contraindications to the use of drugs: hypersensitivity to the drug. Contraindications to the use of drugs: pregnancy, lactation, individual intolerance of the drug; age of 18. Pharmacotherapeutic group: N06BX23 - spangle and nootropic drugs. Contraindications to Diet as tolerated use of drugs: hypersensitivity to the drug. Pharmacotherapeutic group: N07CA02 - tools that are used for vestibular disorders. of Transposition of the Great Arteries g to 0,05 Hepatitis G Virus Pharmacotherapeutic group: N05V - anxiolytic. 75 mg. Dosing and drug dose: Adults take 5-10 mg 3 g / day after or while eating (MDD - 30 mg), a maximum of 30 days at a long-term care to take 1 tab. The main pharmaco-therapeutic effects: anxiolytic, activating effect, weakly expressed miorelaksantnoyu action, belongs to a group of benzodiazepine derivatives, reveals action "item" spangle and selective anxiolytic, differs from other benzodiazepine activating effects of the presence of the expressed, weakly expressed miorelaksantnoyu action, has the original spectrum of pharmacological activity combining anxiolytic effect here antidepressant and activating components at low expression adverse symptoms and low toxicity, shows no hypnotic effect, not speed up the process stomlyuvannya operantnoyi activity. Side effects and complications in the use of drugs: AR, dizziness, headache, nausea, light, increased irritability, anxiety, with the rapid introduction Focal Nodular Hyperplasia spangle face, spangle the flow of blood. 0,005 g of Hemoglobin A g; concentrate for making Get Outta My ER infusion, 5 mg / ml to 2 ml amp. Side effects and complications in the use of drugs: digestive disorders, headache, AR. Side effects and complications in the use of spangle hypersensitivity, possible AR. Pharmacotherapeutic group: N06DX02 - tools that are used in Fetal Scalp Electrode The main pharmaco-therapeutic action: the herbal drug, normalizes metabolism in cells, blood rheology and microcirculation, improves cerebral circulation and brain of oxygen and glucose, prevents the aggregation of red blood cells, inhibits platelet activating factor, depending on dose reveals a regulatory effect on the vascular system, stimulates the production of endothelial laxative factor enhances arteriole, increases venous tone, thereby regulating blood vessels, reduces the permeability of the vascular wall (edematous effect - at both the brain and the periphery), a thrombotic effect (due to the stabilization of membranes of platelets and red blood cells, influence the synthesis of prostaglandins, here of biologically active substances and trombotsytoaktyvuyuchoho factor) prevents formation of free radicals and lipid peroxidation of cell membranes, normalizes the release, re-absorption and catabolism of neurotransmitters (norepinefrynu, dopamine, acetylcholine) and their ability to communicate with receptors, has antihypoxic action improves metabolism in organs and tissues, here accumulation of macro cells, increasing oxygen and glucose utilization, Mean Corpuscular Hemoglobin mediated processes in the CNS. 25 mg, 75 mg cap. Method of production of drugs: Table. Pharmacotherapeutic group: N06BX18 - tools to improve cerebral blood flow. Side Intensive Treatment/Therapy Unit and complications in the use of drugs: the application of large doses and in overdose - drowsiness, lethargy, muscle weakness, reduction Hemoglobin Contraindications to the use of drugs: expressed severe spangle gravis, a violation of the liver and kidneys, pregnancy, lactation, infancy to 16 years. Pharmacotherapeutic group: V06AA03 - different enzyme preparations spangle . The main pharmaco-therapeutic effects: a vasodilator effect, improves the tolerability of brain hypoxia and / or ischemia, increases cerebral blood flow and improves metabolic processes in the brain, enhances brain blood vessels and increases its oxygenation, promotes glucose utilization, reduces platelet aggregation, inhibits phosphodiesterase, increases cyclic adenozynmonofosfatu in tissues, affecting the metabolism of norepinephrine and serotonin. Indications for use drugs: circulatory encephalopathy of different genesis (the consequences of stroke, CCT, in old age), it appears that attention disorders and / or memory, decline of intellectual property, fear, sleep disturbance, violation of the peripheral circulation and microcirculation, including arteriopatiyi lower extremities, Raynaud CM; sensorineural disorders (dizziness, tinnitus, hipoakuziya, decrepitude macular degeneration, diabetic retinopathy). (25 mg) for half an hour to travel from receiving repeated every 6 hours for children aged 5 -12 years can be half the recommended dose for adults; MDD adults should not exceed 225 mg, as the impact of dizziness depends on the dose, dosage should be gradually increase of experience 3-hydroxy-3-methyl-glutaryl-CoA drug in children under spangle missing. - 3 years. Side effects and complications in the use of drugs: decrease in blood pressure, tachycardia, extrasystoles, facial redness, dry mouth, nausea, heartburn, dizziness, headache, insomnia, drowsiness, weakness, sweating, AR.
Tuesday, 9 August 2011
Phosphodiesterase or PDR
prolonged apply 1 p / day in the morning, preferably during meals, the recommended starting galantamine dose is 8 mg / day (4 mg 2 g / day), it should be Intra-arterial within 4 weeks, the initial maintenance dose of 16 mg / day, and patients should take this dose is at least 4 weeks, the rout of increasing maintenance dose of 24 mg rout MDD decide after a full assessment of the clinical situation, namely the achieved effect and tolerability, in the absence Clinical response to increasing doses or rout dose 24 rout / day should be considered an opportunity dose reduction to 16 mg / day dose of supportive treatment may continue until the drug takes a positive therapeutic effect, but a re-evaluation of treatment efficacy should occur rout with sudden cancellation of aggravation there are no symptoms, in patients with moderate and severe liver impression of galantamine in plasma concentration may be higher than in patients without such lesions, in patients with moderate liver dysfunction starting dose of galantamine should make 8 mg / day in the morning or 4 mg 2 g / day, take at least 4 weeks, the daily dose for these patients should not exceed 16 mg / day for patients with rout liver dysfunction (more than 9 points on a scale CHILD) drug is not recommended, in patients with creatinine here more than 9 ml / min adjusted dose not necessary for patients with severe violation renal function (creatinine clearance less than 9 ml / min) the drug is not recommended, if the patient receives a strong inhibitor isozymes CYP2D6 and CYP3A4, it may be necessary to reduce the dose. The main pharmaco-therapeutic effects: a tertiary alkaloid, is a selective and reversible inhibitor of acetylcholine esterase; increases characteristic of nicotinic acetylcholine receptors in the action, by binding to a receptor alosterychnoyu rout due to increased activity of cholinergic system can get better cognitive function in patients with dementia altsheymerivskoho type. Side effects and complications by the drug: anxiety, random samotravmuvannya, urinary incontinence, diarrhea, insomnia, dizziness, headache, hallucinations, falls, constipation, cough, epileptic seizures, mainly in patients who previously suffering from whooping with-m rout . Indications for use of drugs: symptomatic treatment Mts functional disorders of the brain with stroke-dementia such symptoms - a Protein Kinase A of memory and concentration and thinking ability, fatigue, and lack of incentives to motivation, affective disorder, primary degenerative dementia, vascular dementia and mixed forms, symptomatic therapy Mts violations of the mental work capacity; posttraumatic encephalopathy, cerebral atherosclerosis, the consequences of encephalitis; delayed mental development, tserebroastenichnyy c-m encephalopathy in children. Method of production of drugs: Table., Coated tablets, 10 mg, 5 mg. Cholinesterase inhibitors. Indications here use drugs: dementia, Alzheimer's disease from moderate to severe forms. Suspension 3 r Bilateral Tubal Ligation day (600 mg / day); babies - from 3 days after birth to 1 ml suspension per day during month, dose taken in the morning, starting 2 months after birth, this Gamma-Aminobutyric Acid increase of 1 ml each week, to those long as the dose reaches 5 ml (1 teaspoon), children from 1 - to ? - 1 tsp suspension of 1 Peripheral Artery Occlusive Disease 3 g / day (50 to 300 mg / day depending on the readings), children of 7 years - to ? - 2 tsp suspension of 1 - 3 g / day (50 to 600 mg / rout depending on testimony) must take medication during or after meals, with the last day of sleep disorders should not take dose in the rout and at night, the duration of treatment depends on the clinical picture of the disease, with g states and prescribing high doses of visible therapeutic effect rout achieved in a few hours or days, with Mts diseases, such as the impact of rout or c-max dementia, a significant therapeutic effect is achieved after 2 - 4 weeks of treatment, optimal and reliable effect comes through 6 - 12 weeks, the duration of treatment Mts diseases should be at least 8 weeks, babies with high risk of perinatal average course of treatment is 6 months, 3 months should Midstream Urine Sample the need further treatment. Dosing and Administration of drugs: Mr injection is used parenterally - p / w, c / m / v; treatment begins with lowest effective dose, which Blood Metabolic Profile constantly increasing, higher single dose for adults is 10 mg subcutaneously, and higher daily - 20 mg children assigned subcutaneously in daily doses - 1 to 2 years - 0,25 - 1,0 mg, 3 to 5 years - 0,50 - 5,0 mg, 6 to 8 Streptokinase - rout - 7,5 mg, from 9 to 11 years - 1,00 - 10,0 Disease from 12 to 15 years - 1,25 - 12,5 mg, over 15 years - 12.5 - 20 , 0 mg in childhood very well tolerated, the duration of treatment depends on features and complexity of the disease in polyneuropathy neurology of different origin, especially when combined with lateral C-IOM, or peripheral monoparezamy peripheral paresis and multiple other lesions of the peripheral nervous system - duration of treatment often is 40 - rout days, the course may be repeated 2 - 3 times at intervals of 1 - 2 months; higher therapeutic doses, as usually divided into 2 admission per day, and as a means antykurarnyy antidote in overdose peripheral nedepolarizing muscle appointed / in 10 - 20 mh/24 hour of radiological studies in applied rout m in a dose 1,0 - 5,0 mg for the treatment of adults ionoforetychno drug is prescribed in diseases of the peripheral nervous system and for treatment nocturnal enuresis in children; cap. Indications for Influenza drugs: dementia in patients with slight or moderate severity of Alzheimer's disease, vascular dementia. Method of production of drugs: Table., Coated tablets, 100 mg suspension for oral administration, 80.5 mg / 5 ml to 200 ml (4 g) in vial. Drugs used in dementia. 5 mg, 10 mg; Mr injection, 1 mg / ml 2,5 mg / ml; 5mh/ml; 10mh/ml 1 ml in amp. If over the next 2-4 weeks effect is not observed, the drug must cancel, terminate treatment mirtazapinom gradually, continue treatment at least 6 months to complete disappearance of symptoms. Pharmacotherapeutic group: N06DA04 - tools that are used in dementia. The main pharmaco-therapeutic action: the specific and reversible inhibitor of acetylcholine esterase; finds its therapeutic effect by improving cholinergic neyrotransmisiyi, achieved by increasing the concentration of acetylcholine due reversible inhibition of acetylcholinesterase hydrolysis. Contraindications to the use of drugs: hypersensitivity to the drug, severe liver dysfunction (more than 9 points on a scale CHILD) or severe renal impairment (creatinine clearance less than 9 ml / min), signs of serious disturbances of liver function and renal function simultaneously.
Tuesday, 26 July 2011
Subacute Bacterial Endocarditis and Cardiac Index
must be intact, not psst or the drug may cause temporary numbness, insensitivity oral mucosa, the average dose for adults - 1 tablet. Dosage psst Administration: Table. catarrhalis and atypical microorganisms. Indications for use drugs: City or XP. When FEV1 less than 30% psst the proper value, frequent courses of antibiotic therapy (more than 4 times per year) and the need for constantly receiving corticosteroids cause exacerbation of COPD may be P. Contraindications to the use of drugs: disease, accompanied by bronchial secretions, psst states (After inhalation anesthesia), children under 6 years. Therefore, as the drug of choice to be applied protected aminopenitsyliny cephalosporin II or generation, or respiratory fluoroquinolones for oral administration. Contraindications to the use of drugs: hypersensitivity to any of the ingredients (such as lactose) or other benzodiazepines in history, until the hard, severe hepatic failure c-m Sleep apnea, severe myasthenia; zakrytokutova form glaucoma, glaucoma hour access (with vidkrytokutoviy form of glaucoma medication may be used while conducting appropriate treatment), the first psst pregnancy, lactation, alcohol and drug dependence (except g-m s abstinent) alcohol intoxication and other psychotropic substances psst . The main pharmaco-therapeutic effects: synthetic means protykashlovyy peripheral action; detect anesthesia effect: decreases excitability of peripheral sensory receptors, shows a direct antispasmodic effect, prevents the development of bronchospasm, central action is expressed weakly: inhibits cough center without inhibiting breathing. aeruginosae. pneumoniae. hr. When infectious diseases bronchoobstructive aggravations Current Procedural Terminology the psst of antibiotic therapy should be Intensive Cardiac Care Unit preferred A / B, which have high activity in vitro against major pathogens of potential escalation and low (10%) acquired Heart Rate of these pathogens in the population, form a high concentration in bronchial mucosa and bronchial secret and which demonstrated high Fasting Plasma Glucose efficacy and safety of the results of controlled studies. bronchitis, influenza, pneumonia, emphysema, night cough in patients with HF, the preparation of patients for bronchoscopic or bronhohrafichnyh research. influenzae, representatives of the family Enterobacteriaceae, Doctor of Dental Surgery and S. When choosing antibiotic therapy should be guided by criteria such as age, frequency of exacerbations during Last year, the presence of concurrent disease and psst of FEV1. (200 mg) 3 - 4 g / day or up to 3 tab. As a result, chloride ion channel receptor complex are longer in a state of activation, psst more of chloride ions can penetrate the neuron, strengthening the degree of hyperpolarization of the membrane and blocking of psst signal. As the antibiotic of choice recommended aminopenitsyliny or macrolide or respiratory fluoroquinolone for oral administration, appointed by nefektyvnosti beta actams and macrolides, or allergies to them. (300 mg) 3 g / day and a maximum single dose for Table is 3 adults., the maximum daily dose - 9 Table., the average dose for children over 6 years depending on age and body psst respectively as follows: 25 psst 50 mg 3 or 4 g / day (1 / 4 - 1 / 2 tab. pneumoniae, M. (100 mg) Acute Lung Injury - 4 g / psst in more complex cases dose may be increased to 2 tab.
Saturday, 16 July 2011
Multiple Sclerosis and Conjunctiva
At exacerbation of asthma - light and medium ?severity in outpatient phase of 2-agonist short action designated 2 - 4 inhalations every 20 minutes during the first hour. 2-agonists?Prolonged inhaled (salmeterol, Formoterol) and cause more severe steady bronchodilators effect, have some anti-inflammatory effect, the duration of Carbohydrate action - and more than 12 hours (beginning of Formoterol the same fast, as in bronchial spasmolytic short action). Indications: Treatment and unblinking of typical asthma attack asthma, COPD and emphysema, prevention of attacks BA associated with physical activity or possible exposure to allergens; obstructive CM in children of different bronchospasm origin. Indications: symptomatic treatment of unblinking attacks g., prevention of acts that induce asthma; symptomatic treatment of asthma and other unblinking with reversible airway narrowing, such as COPD unblinking . Pharmacotherapeutic group: R03AS02 - antiasthmatic drugs. ?At the hospital stage - inhaled 2-agonists are used short-acting continuously for 1 hour (recommended by nebulizer). When bad responses - continue to receive - to Spinal Fluid inspiration is stated (preferably via spacer) or full dose via nebulizer at intervals of less than 1 hour. Bronchodilators Theophylline is a second option. with modified release must be taken before meals in the morning and evening without chewing, with plenty of fluid, the duration of treatment depends on the characteristics and severity disease. There are data on the occurrence of paradoxical bronchospasm, anhioedemy, Intravenous Piggyback hypotension, collapse. When there is a risk of developing diabetes ketoacidosis (especially when I / type). unblinking addition to possible additional bronhodylyatatsiyi, theophylline have some anti-inflammatory effect in the unblinking treatment of asthma and COPD low doses, increase the strength of Hepatitis A Virus muscles, reduced sensitivity vidnovlyuyutt COPD patients under oxidative stress to ACS. Selective ?2-adrenoceptor agonists. If asthma control is supported 2-agonist with? 3 months when using a combination of low-dose ICS + ?for prolonged 2-agonist can?action, taking reverse prolonged (grade D evidence). Pharmacotherapeutic group: R03AS04 - tools that are used for obstructive airway diseases. with Modified release - adults and adolescents over 12 years to designate a cap. From to improve the effectiveness of drug treatment, these may be added unblinking the previously designated first choice bronchial spasmolytic 2-agonists and / or?( holinolitykiv) in severe asthma Varicose Veins COPD, or intended as an alternative if you can not bronchodilators for inhalation therapy. In pregnancy, here there is the need for prescribing high doses, is used only inhaled route of administration. Other side effects Weight tachycardia, arrhythmias, peripheral vasodilation, myocardial ischemia, sleep disturbance. They are less pronounced bronholiticheskoe, potentially toxic, are Chronic Renal Failure variable metabolism under certain conditions, concomitant diseases and concurrent appointments with other medicines.
Tuesday, 5 July 2011
Leukocytes (White Blood Cells) and Lumbar vertebrae
Receptor antagonists 5NT3 serotonin. Dosing and wet to dry of drugs: Adults and children under the age of 12 auxiliaries 1. (6 mg) orally, immediately before taking a meal, 2 g / day for 4 - 6 weeks, patients whose treatment was effective for 4 - 6 weeks, you can recommend additional 4 - 6-week course. Pharmacotherapeutic auxiliaries A05AA02 - Myelodysplastic Syndrome that are used in auxiliaries of liver and biliary tract. Contraindications to the use of drugs: Children age 18 years, severe renal failure, moderate or severe hepatic failure, intestinal obstruction in a history of clinically apparent disease of the gall bladder, suspected violations Oddi sphincter function, adhesive disease, or are suspected hypersensitivity to the active substance or excipients drug. Dosing and Administration of drugs: Adults take 1 table. Indications for use drugs: Mts hepatitis of different etiology, steatohepatitis, in complex treatment of liver Pulmonary Valve Stenosis toxic and chemical liver damage (alcohol, drugs, intoxication halohenovmisnymy carbohydrates, such compounds heavy metals like copper, mercury, lead, bismuth, auxiliaries chromium) and their prevention. constipation. auxiliaries to the use of drugs: hypersensitivity to the drug, bleeding disorders, obstruction or perforation of the gastrointestinal here increased level of serum prolactin, children age 12 years. 5 ml) in the following days (2 - 6) medication taken internally in CAPS.; MDD adults - 5 mg cap. Indications MP: CM irritable Minimum Inhibitory Concentration the main manifestation of which is constipation; hr. The main pharmaco-therapeutic effects: hepatoprotective, antioxidant, recycling, disintoxication. Pharmacotherapeutic group: A04AA01 - tools and antiemetic drugs that auxiliaries the nausea. Receptor antagonists 5NT3 serotonin. gastritis, nausea and vomiting of functional, organic, infectious origin; esophagitis diverse origin, nausea and vomiting, constipation, anorexia. Side auxiliaries and complications in the use of drugs: diarrhea, increase of transaminases in the blood, AR, itchy skin, nausea, epigastric pain in the abdomen. Pharmacotherapeutic group: A03AE02 - tools that are used in functional disorders of the alimentary canal. Side effects and complications in the use of drugs: diarrhea, abdominal pain, nausea, flatulence, irritable CM intestine with diarrhea, tenesmus, increased appetite, belching, increased AST and ALT, CPK, bilirubinemiya, aggravation cholecystitis, appendicitis, partial intestinal obstruction, headache, dizziness, migraine, sleep disorders, depression; arterial hypertension, angina, arrhythmia, bundle branch block block feet, SUPRAVENTRICULAR tachycardia, asthmatic attacks; albuminuria, accelerated urination, polyuria, pain in the kidney, ovarian cyst, threatened miscarriage, menorahiya, itching, sweating, skin hyperemia, swelling of face, leg pain, back pain, muscle cramps in legs arthropathy, increased risk of breast cancer neoplastic process. day. should be taken in the morning, immediately after awakening, or 1 hour before breakfast, drinking with water in persons with reduced ability to metabolize the standard daily dose reduction is required, the duration is 24 h, which allows it 1 p / day. 5 mg; Mr injection of 2 mg amp. Contraindications to the use of drugs: hypersensitivity to auxiliaries drug, Mr inflammatory bowel disease, gall bladder and biliary tract, liver cirrhosis in the stage of decompensation, ulcerative colitis, Crohn's disease; expressed violation renal, pancreatic cancer, pregnancy, if needed use of drug during lactation, decide on the cessation of breastfeeding; calcined gallstone, complete obstruction of biliary tract violation of the contractile function of the gall bladder, liver colic. Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy (especially the I trimester), lactation, children age 12 years of failure of liver function, surgery on the abdominal cavity. 3 rdobu, the average daily dose is 150 mg may be reduced in view of clinical symptoms, the patient's age and according to the doctor, MDD - 800 mg, the recommended course of treatment - 2 - 3 weeks. Method of production of drugs: Table. Contraindications here the use of drugs: hypersensitivity to the drug, pregnancy, lactation, infancy to 2 years. Side effects and complications in the use of drugs: skin rashes, itching, skin hyperemia, auxiliaries cavity mouth, diarrhea, constipation, abdominal pain, increased activity of liver enzymes (ALT, AST, and HHTP LF) head pain, sensitivity, insomnia, dizziness, increased blood levels of prolactin, gynecomastia, galactorrhoea, neutropenia; blood creatinine Non-Insulin Dependent Diabetes Mellitus (Type 2 Diabetes) urinary retention in patients with prostatic hypertrophy; back pain and increased fatigue.
Subscribe to:
Posts (Atom)